Aurobindo Pharma Limited
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)
What Aurobindo files
- Others79
- Updates76
- Investor Meet65
- Important35
- JV/Acquisition25
- Board Meeting11
Aurobindo Pharma has concluded its share buyback via a tender offer, extinguishing 0.54 Cr equity shares. The buyback was executed at ₹1,475 per share, totaling up to ₹800 Cr. This move reduces the company's total issued share capital from 58.08 Cr to 57.54 Cr shares, enhancing shareholder value. The reduction...
Aurobindo Pharma Limited has informed the Exchange about Buyback
Aurobindo Pharma's Board has approved a share buyback of up to 54,23,728 shares at INR 1,475 each, amounting to 800 Cr. This buyback, representing 0.93% of the paid-up capital, will be via a tender offer. The company has set April 17, 2026, as the record date. Only shareholders who hold...
Aurobindo Pharma's Board has approved an interim dividend of Rs. 4.00 per share (400%). August 8, 2025, is the Record Date, meaning shareholders holding shares by this date will be eligible for the dividend. The payment is scheduled for on or before August 21, 2025. This provides a direct cash...
Aurobindo Pharma (AUROPHARMA) board has greenlit an interim dividend for FY25-26. Shareholders will receive Rs. 4.00 per equity share. To be eligible, ensure your shares are in your demat by the August 8, 2025 Record Date. The payout is set to hit accounts on or before August 21, 2025. A...